Results from the phase 2 RESONATE™-17 trial: Efficacy and safety of Ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma with Del17p

被引:0
|
作者
Stilgenbauer, S. [1 ]
Jones, J. A. [2 ]
Coutre, S. E. [3 ]
Mato, A. R. [4 ]
Hillmen, P. [5 ]
Tam, C. [6 ]
Osterborg, A. [7 ]
Siddiqi, T. [8 ]
Thirman, M. J. [9 ]
Furman, R. R. [10 ]
Ilhan, O. [11 ]
Keating, M. [12 ]
Call, T. G. [13 ]
Brown, J. R. [14 ]
Stevens-Brogan, M. [15 ]
Li, Y. [15 ]
Clow, F. [15 ]
James, D. F. [15 ]
Chu, A. D. [15 ]
Hallek, M. [16 ,17 ]
O'Brien, S. [12 ]
机构
[1] Univ Ulm, D-89069 Ulm, Germany
[2] Ohio State Univ, Div Hematol, Columbus, OH 43210 USA
[3] Stanford Univ, Sch Med, Div Hematol, Stanford Canc Ctr, Stanford, CA 94305 USA
[4] Hackensack Univ, Med Ctr, Hackensack, NJ USA
[5] Leeds Teaching Hosp, St James Inst Onco, Leeds, W Yorkshire, England
[6] Peter MacCallum Canc Ctr, East Melbourne, Australia
[7] Karolinska Univ Hosp Solna, Dept Hematol, Solna, Sweden
[8] City Hope Natl Med Ctr, Dept Hematol Hematopoiet Cell Transplantat, Duarte, CA 91010 USA
[9] Univ Chicago Med, Hematol Oncol Sect, Chicago, IL USA
[10] Weill Cornell Med Coll, Div Hematol Oncol, New York, NY USA
[11] Ankara Univ, Fac Med, TR-06100 Ankara, Turkey
[12] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[13] Mayo Clin, Div Hematol, Rochester, MN USA
[14] Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA
[15] Pharmacyclics Inc, Sunnyvale, CA USA
[16] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany
[17] Ctr Integrated Oncol Cologne Bonn, Cologne, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
V291
引用
收藏
页码:92 / 92
页数:1
相关论文
共 50 条
  • [31] Results of a phase I trial of the proteasome inhibitor carfilzomib in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL).
    Woyach, Jennifer Ann
    Flynn, Joseph M.
    Jones, Jeffrey Alan
    Andritsos, Leslie A.
    Lucas, Margaret
    Chase, Weihong
    Yang, Ying
    Lucas, David M.
    Sass, Ellen
    Waymer, Sharon
    Ling, Yonghua
    Jiang, Yao
    Phelps, Mitch A.
    Byrd, John C.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [32] Outcomes of first-line treatment for chronic lymphocytic leukemia (CLL) with 17p deletion (del17p)
    Strati, Paolo
    Keating, Michael J.
    O'Brien, Susan Mary
    Ferrajoli, Alessandra
    Burger, Jan Andreas
    Faderl, Stefan
    Jain, Nitin
    Wierda, William G.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [33] Zanubrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final results and correlative analysis of lymphocytosis
    Xu, Wei
    Yang, Shenmiao
    Zhou, Keshu
    Pan, Ling
    Li, Zengjun
    Gao, Sujun
    Zhou, Daobin
    Hu, Jianda
    Feng, Ru
    Huang, Haiwen
    Wang, Tingyu
    Li, Dengju
    Ji, Meng
    Guo, Haiyi
    Zhao, Xia
    Wu, Binghao
    Yu, Yiling
    Wang, Yu
    Huang, Jane
    Novotny, William
    Li, Jianyong
    LEUKEMIA & LYMPHOMA, 2023, 64 (03) : 712 - 716
  • [34] A phase I trial of the intravenous Hsp90 inhibitor alvespimycin (17-DMAG) in patients with relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma
    Maddocks, Kami
    Hertlein, Erin
    Chen, Timothy L.
    Wagner, Amy J.
    Ling, Yonghua
    Flynn, Joseph
    Phelps, Mitch
    Johnson, Amy J.
    Byrd, John C.
    Jones, Jeffrey A.
    LEUKEMIA & LYMPHOMA, 2016, 57 (09) : 2212 - 2215
  • [35] A PHASE 2 STUDY OF THE BTK INHIBITOR IBRUTINIB IN GENETIC RISK-STRATIFIED RELAPSED AND REFRACTORY PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL)
    Maddocks, K.
    Flynn, J. M.
    Andritsos, L. A.
    Awan, F.
    Woyach, J. A.
    Grever, M. R.
    Stefanos, M.
    Lynch, J.
    Johnson, A. J.
    Byrd, J. C.
    Jones, J. A.
    HAEMATOLOGICA, 2014, 99 : 522 - 522
  • [36] Treatment of refractory autoimmune hemolytic anemia with venetoclax in relapsed chronic lymphocytic leukemia with del(17p)
    Marcelo Pitombeira de Lacerda
    Nayara Ribeiro Guedes
    Patricia Eiko Yamakawa
    Andre Domingues Pereira
    Ana Rita Brito Medeiros da Fonseca
    Maria Lourdes Lopes Ferrari de Chauffaille
    Matheus Vescovi Goncalves
    Mihoko Yamamoto
    Celso Arrais Rodrigues
    Annals of Hematology, 2017, 96 : 1577 - 1578
  • [37] Treatment of refractory autoimmune hemolytic anemia with venetoclax in relapsed chronic lymphocytic leukemia with del(17p)
    de Lacerda, Marcelo Pitombeira
    Guedes, Nayara Ribeiro
    Yamakawa, Patricia Eiko
    Pereira, Andre Domingues
    Medeiros da Fonseca, Ana Rita Brito
    Lopes Ferrari de Chauffaille, Maria Lourdes
    Goncalves, Matheus Vescovi
    Yamamoto, Mihoko
    Rodrigues, Celso Arrais
    ANNALS OF HEMATOLOGY, 2017, 96 (09) : 1577 - 1578
  • [38] Health-related quality of life outcomes associated with zanubrutinib versus ibrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma: results from the ALPINE Trial
    Tam, Constantine S.
    Lamanna, Nicole
    O'Brien, Susan M.
    Qiu, Lugui
    Yang, Keri
    Barnes, Gisoo
    Wu, Ken
    Salmi, Tommi
    Brown, Jennifer R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (11) : 1497 - 1503
  • [39] Ibrutinib versus rituximab in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma: a randomized, open-label phase 3 study
    Huang, Xiaojun
    Qiu, Lugui
    Jin, Jie
    Zhou, Daobin
    Chen, Xiequn
    Hou, Ming
    Hu, Jianda
    Hu, Yu
    Ke, Xiaoyan
    Li, Junmin
    Liang, Yingmin
    Liu, Ting
    Lv, Yue
    Ren, Hanyun
    Sun, Aining
    Wang, Jianmin
    Zhao, Chunting
    Salman, Mariya
    Sun, Steven
    Howes, Angela
    Wang, Jingzhao
    Wu, Peng
    Li, Jianyong
    CANCER MEDICINE, 2018, 7 (04): : 1043 - 1055
  • [40] Autoimmune Hemolytic Anemia and Immune Mediated Thrombocytopenia in the Phase III RESONATE™ Study of Ibrutinib Vs Ofatumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Including a Case Report
    Montillo, Marco
    O'Brien, Susan
    Tedeschi, Alessandra
    Hillmen, Peter
    Dearden, Claire
    Gill, Devinder
    Brown, Jennifer R.
    Barrientos, Jaqueline C.
    Mulligan, Stephen
    Furman, Richard R.
    Cymbalista, Florence
    Plascencia, Clara
    Chang, Stephen
    Hsu, Emily
    James, Danelle F.
    Byrd, John C.
    BLOOD, 2014, 124 (21)